US 9353372
Compositions and their uses directed to huntingtin
granted A61PA61P25/00A61P25/14
Quick answer
US patent 9353372 (Compositions and their uses directed to huntingtin) held by Ionis Pharmaceuticals, Inc. expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P25/00, A61P25/14, A61P25/28